-
Study aim
-
General goal
Use of Cucumis melo L seeds in the treatment of lower urinary tract symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH)
-
Design
-
Clinical trial with control group, with parallel groups, double-blind, randomized, phase 2 on 80 patients.
-
Settings and conduct
-
This study is a prospective human clinical trial ,that will be done ,on 80 men with benign prostatic hyperplasia (BPH) in the age group of 45 to 75 years, who referred to Hasheminejad Hospital clinic and had symptoms of lower urinary tract symptoms (LUTS).
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria
All patients aged 45 to 75 years with BPH, including at least one of the following, have an International Score of Prostate Symptoms (IPSS) greater than 13 at screening, a PSA greater than 3 ng / ml, and a prostate volume greater than 30 mm. Cube diagnosed by ultrasound, and patients who are able and willing to sign written consent.
Exclusion criteria
Surgery, infection, lower urinary tract disease (bladder stones, neurogenic bladder, bladder malignancy, urethral stricture, hematuria), Diabetes, Heart disease (heart failure, MI, unstable angina), uncontrolled hepato-renal disease, use of effective drugs Bladder and prostate (anticholinergics, sympathomimetics, antidepressants) Patients who are unable to use oral medication.
Perform any drug intervention simultaneously.
Allergy to medicinal plants.
-
Intervention groups
-
Intervention group: Will received Tamsulosin (0.4 mg per night, 1 piece) with Cucumis melo L seeds 500 mg oral capsule three times daily after each meal for up to 6 weeks. The medicine is made by a pharmacist.
The control group received Tamsulosin (0.4 mg 1 per night) with placebo oral capsules (500 mg of starch) three times daily after each meal for up to 6 weeks.
-
Main outcome variables
-
Patients' urinary symptoms